Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice

Brain Research

Volumn 905, Issue 1-2, 2001, Pages 142-151

  Dracheva, Stella ^a   Haroutunian, Vahram ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

D1 receptor transgenic mice; D2 receptor knockout mice; Locomotion; Parkinson's disease; SKF 81297

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOKINESIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; TRANSGENIC MOUSE;

ANIMALS; BRAIN; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FRONTAL LOBE; GAIT DISORDERS, NEUROLOGIC; HYPOKINESIA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; NEOSTRIATUM; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0035968037     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02522-7     Document Type: Article

References (32)

1. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
2. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
3. Selective D-1 dopamine receptor agonist treatment of Parkinson's disease
4. Stress, depression and the mesolimbic dopamine system
5. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase
6. Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: Paradoxical elevation of grooming syntax
7. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: A finding generic to four new, selective dopamine D1 receptor antagonists
8. The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia
9. Paradoxical locomotor behavior of dopamine D1 receptors transgenic mice
10. Altered striatal function in a mutant mouse lacking D1A dopamine receptors
11. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice
12. Dopamine (3-hydroxytyramine) and brain function
13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: Electrophysiological and behavioral studies
14. The rationale for the use of dopamine agonists in Parkinson's disease
15. A-77636: A potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets
16. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice
17. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations
18. Protein measurement with folin reagent
19. Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats
20. Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats
21. Dopamine receptors: From structure to function
22. ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
23. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine
24. ABT-431: The diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: In vitro characterization and effects in animal models of Parkinson's disease
25. Are neostriatal dopamine receptors co-localized?
26. Behavioural pharmacology of 'D-1-like' dopamine receptors: Further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors
27. Dopamine D1 receptors: Efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents
28. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
29. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization
30. Improved therapies for Parkinson's disease: Life beyond dopamine D2/D3 receptor agonists
31. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors
32. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses